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Summary. The members of the Fos protein family might 
be subdivided in two groups, according to their ability to 
transform rodent fibroblasts, transforming (c-Fos and 
FosB) and non-transforming (Fra-l and Fra-2) proteins. 
Members of these groups are differently activated in 
response to external stimuli and posses different 
structural features. Importantly, whilst c-Fos and FosB 
contain multiple transactivation modules in their N- and 
C-terminal parts, transactivation domains are absent in 
the non-transforming Fos proteins. As a result, Fra-l and 
Fra-2 though efficiently form dimers with the Jun 
proteins, are weak transcriptional activators and inhibit 
the c-Fos-dependent activation in transient transfection 
assay. The numerous experiments performed with the 
different Fos mutant proteins with impaired transforming 
ability, as well as with chimeric proteins revealed the 
importance of the transactivation function for 
transformation. Fra-1 and Fra-2 proteins albeit 
ineffectively triggering oncogenic transformation, are 
abundant in ras- and src-transformed murine and 
chicken fibroblasts, in neoplastic thyroid cells and in 
highly malignant mouse adenocarcinoma cells, which 
underwent mesenchymal transition. The abundance of 
the non-transforming Fos proteins in these systems 
might be mediated by a positive AP-l-dependent 
feedback mechanism, as well as by wnt signals. 
Furthermore, the manipulation of the Fra-l expression 
level in thyroid and mammary tumor cells modulated the 
transcription of several tumor progression markers and 
affected cell morphology and invasiveness. These recent 
data demonstrate a novel function of non-transforming 
Fos proteins in the maintenance and progression of the 
transformed state. Interestingly, this function is 
independent of the documented invalidity of the Fra-l 
and Fra-2 proteins as transcriptional activators in rodent 
fibroblasts. 
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Introduction 
The Fos family consists of four cellular proteins, c- 
Fos, FosB, Fra-l and Fra-2. In addition, as a result of 
alternative splicing, a dominant negative mutant of 
FosB, FosB2, may naturally occur (Mumberg et al., 
1991; Nakabeppu and Nathans, 1991). When activated 
by an external stimulus, Fos interacts with one of three 
cellular members of the Jun protein family (c-Jun, JunB, 
or JunD) to form an AP-1 (activating protein-l) complex 
(Angel and Karin, 1991). Fos-Jun dimers activate 
transcription by the binding to the TGACtGTCtAA 
sequence elements, TREs (TPA-responsive elements), 
located in the promoters/enhancers of target genes (Lee 
et al., 1987). The transcriptional activation depends on 
direct contacts between AP-l  and the basal 
transcriptional machinery (Metz et al., 1994a,b; Funk et 
al., 1997), andtor on the binding of transcriptional 
coactivators, CBPlp300 (Bannister and Kouzarides, 
1995; Bannister et al., 1995) or JAB1 (Jun activation 
domain binding protein 1) (Claret et al., 1996). 
The variety of stimuli inducing Fos synthesis and 
activity, as well as the detection of functional TREs in 
promoters of numerous genes with diverse functions 
suggest a complex and varied biological role of the Fos 
proteins. Indeed, members of this family have been 
implicated in most fundamental processes occurring in 
mammalian cells: cell cycle control (Kovary and Bravo, 
1991, 1992, Balsalobre and Jolicoeur, 1995); apoptosis 
(Preston et al., 1996; Karin et al., 1997); cell 
differentiation (Lord et al., 1993; Baset-SCguin et al., 
1994; Grigoriadis et al., 1994; Rutberg et al., 1996); 
oncogenic transformation (reviewed in Angel and Karin, 
1991) and tumor progression (Reichmann et al., 1992; 
Saez et al., 1995). During the last few years of intensive 
studies, it has become clear that the Fos proteins, 
although being similar in terms of their affinity to TREs 
or dimerization with Jun, regulate different target genes 
and therefore have distinct biological functions. The 
specific functions of different Fos proteins in the 
transcriptional control of certain target genes may result 
from the peculiarities of the regulation of each particular 
member of the Fos family. Additionally, this specificity 
might reflect the differences in their biological features. 







